Opportunity ID: 353862

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942524PCARPIDA
Funding Opportunity Title: DOD Pancreatic Cancer, Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 8
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 29, 2024
Last Updated Date: Apr 29, 2024
Original Closing Date for Applications: Oct 03, 2024
Current Closing Date for Applications: Oct 03, 2024
Archive Date: Nov 02, 2024
Estimated Total Program Funding: $7,360,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The PCARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.

Significant features of the Idea Development Award:

  • Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of pancreatic cancer and ultimately lead to improved outcomes for individuals with pancreatic cancer. The project’s impact on both pancreatic cancer research and patient care should be articulated, even if clinical impact is not an immediate outcome.

  • Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative.

  • Personnel: Personnel are considered a crucial element of the FY24 PCARP Idea Development Award. At least one member of the research team should have experience in pancreatic cancer research, as demonstrated by recent publications and funding. Inclusion of a biostatistician in the study team is encouraged.

  • Research must be based on preliminary data: Although the proposed research must have direct relevance to pancreatic cancer, the required preliminary data, which may include unpublished results from the laboratory of the Principal Investigator(s) (PI[s]), research team, or collaborators named on the application, may be from outside the pancreatic cancer research field. Research should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.

Partnering PI Option for Early-Career Investigator: The FY24 Idea Development Award mechanism is offering a higher level of funding for applications that propose to partner an experienced PI (i.e., Initiating PI, who will serve as the mentor) with an Early-Career Investigator (i.e., Partnering PI) wishing to pursue a career in pancreatic cancer research. The Initiating PI on the Idea Development Award must mentor and collaborate with the Early-Career Investigator (Partnering PI) to promote their career development in pancreatic cancer research. The Early-Career Investigator must meet the specific eligibility criteria described in Section II.C, Eligibility Information. The Initiating PI will be responsible for the majority of the administrative tasks associated with application submission. The Initiating and Partnering PIs each have different submission requirements, as described in Section II.D.2, Content and Form of the Application Submission; however, both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. If recommended for funding, each PI will be named to an individual award within the recipient organization. Projects involving convergence science partnerships are encouraged.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 353862 Full Announcement-FY24 PCARP IDA -> FY24 PCARP Academic Statement.pdf

Folder 353862 Full Announcement-FY24 PCARP IDA -> HT942524PCARPIDA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00286135 Apr 29, 2024 Oct 03, 2024 View

Package 1

Mandatory forms

353862 RR_SF424_5_0-5.0.pdf

353862 AttachmentForm_1_2-1.2.pdf

353862 RR_PersonalData_1_2-1.2.pdf

353862 RR_KeyPersonExpanded_4_0-4.0.pdf

353862 RR_Budget_3_0-3.0.pdf

353862 PerformanceSite_4_0-4.0.pdf

Optional forms

353862 RR_SubawardBudget30_3_0-3.0.pdf

2025-07-12T13:19:12-05:00

Share This Post, Choose Your Platform!

About the Author: